Comment on "Therapeutic Targeting of Syk in Autoimmune Diabetes"

Journal of Immunology - United States
doi 10.4049/jimmunol.1090140
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Promising Epigenetic Approaches Targeting TH17 in Autoimmune Diabetes Among Chronic Hepatitis C Infection

International Journal of Current Microbiology and Applied Sciences
2017English

The Predictive Value of Biopsy of the Pancreas and Its Therapeutic Impact in Autoimmune Diabetes

Journal of Diabetes Mellitus
2014English

Therapeutic Approaches for Latent Autoimmune Diabetes in Adults: One Size Does Not Fit All

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

Latent Autoimmune Diabetes in Adults (LADA) Is Dead: Long Live Autoimmune Diabetes!

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Therapeutic Targeting of STAT3 (Signal Transducers and Activators of Transcription 3) Pathway Inhibits Experimental Autoimmune Uveitis

PLoS ONE
Multidisciplinary
2012English

Control of Autoimmune Diabetes

Science
MultidisciplinaryPhilosophy of ScienceHistory
2000English

Targeting the Fc Receptor in Autoimmune Disease

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2014English

Comment on “Deficient NLRP3 and AIM2 Inflammasome Function in Autoimmune NZB Mice”

Journal of Immunology
AllergyImmunology
2015English

Nivolumab-Induced Autoimmune Diabetes

Journal of Pharmacy Practice and Research
PharmacologyPharmacy
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy